000 01229 a2200385 4500
005 20250513031831.0
264 0 _c19950905
008 199509s 0 0 fre d
022 _a0007-4551
040 _aNLM
_beng
_cNLM
100 1 _aDorval, T
245 0 0 _a[Immunotherapy of malignant diseases].
_h[electronic resource]
260 _bBulletin du cancer
_c1995
300 _a127s-138s p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aCytokines
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aInterferons
_xtherapeutic use
650 0 4 _aInterleukin-2
_xtherapeutic use
650 0 4 _aKidney Neoplasms
_xtherapy
650 0 4 _aLymphoproliferative Disorders
_xtherapy
650 0 4 _aMelanoma
_xtherapy
650 0 4 _aMice
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aNeoplasms, Experimental
_ximmunology
650 0 4 _aNeuroblastoma
_xtherapy
700 1 _aMichon, J
700 1 _aTartour, E
700 1 _aFridman, W H
773 0 _tBulletin du cancer
_gvol. 82 Suppl 2
_gp. 127s-138s
999 _c7542404
_d7542404